cosentyx
novartis europharm limited - secukinumab - arthritis, psoriatic; psoriasis; spondylitis, ankylosing - immunosupressandid - plaque psoriasiscosentyx is indicated for the treatment of moderate to severe plaque psoriasis in adults and children from the age of 6 years old who are candidates for systemic therapy. hidradenitis suppurativa (hs)cosentyx is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adults with an inadequate response to conventional systemic hs therapy. psoriaatilise arthritiscosentyx, üksi või koos metotreksaadi (mtx), on näidustatud ravi aktiivne psoriaatiline artriit täiskasvanud patsientidel, kui vastus eelmisele haigust moduleeriva anti reumaatilised narkootikumide (dmard) ravi on olnud ebapiisav. aksiaal-spondyloarthritis (axspa)anküloseeriva spondüliidi (as, radiograafiline axial spondyloarthritis)cosentyx on näidustatud ravi aktiivse anküloseeriva spondüliidiga täiskasvanud, kes on vastanud õigesti, et tavapärase ravi. non-radiographic axial spondyloarthritis (nr-axspa)cosentyx is indicated for the treatment of active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) evidence in adults who have responded inadequately to non steroidal anti inflammatory drugs (nsaids). juvenile idiopathic arthritis (jia)enthesitis-related arthritis (era)cosentyx, alone or in combination with methotrexate (mtx), is indicated for the treatment of active enthesitis-related arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy. juvenile psoriatic arthritis (jpsa)cosentyx, alone or in combination with methotrexate (mtx), is indicated for the treatment of active juvenile psoriatic arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy.
medicinal oxygen air liquide sante
air liquide santé international - hapnik - kõik muud ravitoimingud - horses; dogs; cats - hapniku lisamisel ja kandegaasina inhalatsiooni ajal anesteesia. hapniku lisamine taastumise ajal.
ikervis
santen oy - tsüklosporiin - sarvkestahaigus - oftalmoloogilised vahendid - raske keratiidi ravi kuiva silmahaigusega täiskasvanud patsientidel, mis ei paranenud hoolimata rebenemise asendajatest.
verkazia
santen oy - tsüklosporiin - conjunctivitis; keratitis - oftalmoloogilised vahendid - ravi raskeid kevadine keratoconjunctivitis (vkc) lastele alates 4 aasta vanusest ja noorukid.
rhokiinsa
santen oy - netarsudil - glaucoma, open-angle; ocular hypertension - oftalmoloogilised vahendid - vähendada kõrgenenud silmasisese rõhu (iop) täiskasvanud patsientidel, kellel on primaarne avatud nurga glaukoomi või hüpertensioon silma.
dolpac 10 tablett
vetoquinol s.a. - prasikvanteel+oksanteel+püranteel - tablett - 50mg+200,28mg+49,94mg 6tk; 50mg+200,28mg+49,94mg 18tk; 50mg+200,28mg+49,94mg 30tk; 50mg+200,28mg+49,94mg 3tk
dolpac 25 tablett
vetoquinol s.a. - prasikvanteel+oksanteel+püranteel - tablett - 125mg+500,7mg+124,85mg 18tk; 125mg+500,7mg+124,85mg 3tk; 125mg+500,7mg+124,85mg 60tk; 125mg+500,7mg+124,85mg 30tk
oftaquix 5 mg/ml silmatilgad silmatilgad, lahus
santen oy - levofloksatsiin - silmatilgad, lahus - 5mg 1ml 5ml 1tk
dolpac 2 tablett
vetoquinol s.a. - prasikvanteel+oksanteel+püranteel - tablett - 10mg+40,06mg+9,99mg 10tk; 10mg+40,06mg+9,99mg 60tk; 10mg+40,06mg+9,99mg 100tk
lecrolyn sine silmatilgad, lahus
santen oy - kromoglütsiinhape - silmatilgad, lahus - 40mg 1ml 10ml 1tk; 40mg 1ml 5ml 1tk